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Replication checkpoint: Preventing mitotic catastrophe
Christine E. Canman
A conserved network of signal transduction pathways
prevents mitosis if DNA is damaged or its synthesis
incomplete. Loss of this checkpoint control is
detrimental to the developing embryo. Recent studies
have shed new light on how the essential ATR and Chk1
protein kinases cooperate to prevent such a crisis.
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In recent years, considerable attention has focused on
understanding how cells monitor and respond to alterations
in DNA structure and integrity. Many of the major players
involved in these responses were initially identified
through genetic experiments in yeast, and considerable
advances have been made in understanding the mecha-
nisms by which these genes collectively induce growth
arrest in the G2 and M phases of the cell cycle [1]. Recent
data, however, suggest that the DNA damage and replica-
tion checkpoint responses have been modified in multi-
cellular organisms to accommodate the cellular processes
that occur during development and differentiation. Central
to these responses in multicellular organisms are the ATM
and ATR protein kinases and their effector kinases, Chk1
and Cds1.
Genetic and biochemical experiments in yeast provided
the foundation upon which we model current checkpoint
pathways in higher eukaryotes. In the fission yeast,
Schizosaccharomyces pombe, six non-essential genes —
Hus1, Rad1, Rad3, Rad9, Rad17 and Rad26 — are required
for both DNA replication and DNA damage checkpoints
[1]. With the exception of Rad26, homologs of each of
these genes have been identified in vertebrates, strength-
ening the view that, in their general organization, the cell-
cycle checkpoint pathways are evolutionarily conserved.
Similar checkpoint defects occur when any one of these
genes is mutated. This is exemplified by the absence of
characteristic phosphorylation events that are associated
with two downstream effector kinases, Chk1 and Cds1.
In fission yeast, Chk1 is typically phosphorylated in
response to agents that damage DNA, whereas Cds1 is
phosphorylated and activated when replication is blocked
[2]. But Chk1, rather than Cds1, appears to be the primary
effector for replication checkpoint control in frogs, flies
and mice.
How are cells prevented from progressing into mitosis
in response to checkpoint signals? Chk1 and Cds1 con-
tribute to growth arrest in fission yeast, at least in part,
by phosphorylating and thereby inhibiting Cdc25. Cdc25
is a dual-specificity phosphatase that activates the cyclin
B–Cdc2 kinase at the G2/M transition by catalysing removal
of an inhibitory phosphate group from residue tyrosine 15
of Cdc2. Phosphorylation of Cdc25 by Chk1 or Cds1
creates a binding site for 14-3-3 proteins, which in turn
sequester Cdc25 in the cytoplasm, preventing Cdc25 from
activating cyclin B–cdc2 in the nucleus [2]. Overall, this
general scheme appears to be conserved in higher eukary-
otes, although there may also be additional controls such
as exclusion of cyclin B from the nucleus and inhibition of
the mitosis promoting Polo-like kinase 1 [3–5].
In fission yeast, the Rad3 protein plays a critical role in
signaling to both Chk1 and Cds1, most likely by direct
phosphorylation of Chk1 or Cds1 in response to the appro-
priate signal [6]. In vertebrates, this role is divided
between two homologs of Rad3: proteins best known by
their acronyms ATM, for ‘ataxia telangiectasia-mutated’,
and ATR, for ‘ataxia telangiectasia and Rad3-related’.
Rad3, ATM and ATR belong to a subfamily of
serine/threonine protein kinases with catalytic domains
related to that of phosphatidylinositol 3-kinase [7]. ATM
is primarily responsible for controlling proper responses to
DNA strand breaks, whereas ATR participates in various
checkpoint responses that occur independently of ATM,
such as those initiated by UV irradiation or hydroxyurea
treatment (which inhibits DNA replication by depleting
dNTP pools).
Overall, ATM and ATR appear to phosphorylate many of
the same substrates in vivo, so they have been considered
to have overlapping functions [7,8]. Perhaps the specificity
of these two kinases is explained by how they respond to
different stimuli. ATM is relatively cell-cycle independent
and its specific activity is increased in response to DNA
strand breaks, such as those created by ionizing radiation
[8]. The activity of ATR, on the other hand, was found not
to increase in response to various DNA damaging agents or
DNA replication inhibitors [9]. Instead, these treatments
were found to induce formation by ATR of nuclear foci
that partially colocalize with a target of ATR — BRCA1,
the product of a breast-cancer susceptibility gene. Changes
in subcellular localization may therefore be the mechanism
by which ATR’s activity towards substrates is regulated.
Although ATM and ATR may share many of the same
substrates in tissue culture cells, drastically different
phenotypes are observed if the gene for either kinase is
disrupted in the whole organism. Mutations in the ATM
gene in humans are responsible for the genetic disorder
ataxia telangiectasia, which is characterized by devastating
and progressive neurodegeneration, increased susceptibil-
ity to the development of cancer, and heightened sensitiv-
ity to radiation [8]. Many of these phenotypes can be
explained by an inability of cells to respond efficiently to
DNA strand breaks. On the other hand, disruption of the
ATR gene in mice leads to early embryonic cell death
which is associated with extensive chromosomal fragmen-
tation, similar to that observed when somatic cells are
induced to prematurely undergo mitosis, also known as
‘mitotic catastrophe’ [10,11]. 
Drosophila embryos lacking the ATR homolog Mei-41,
originally thought to be an ATM homolog, are unable
to perform a developmentally regulated checkpoint at the
midblastula transition which involves a critical slowing
down of cell-cycle progression [12]. Together, these genetic
studies in mice and flies led to the model that ATR is a
true mediator of replication checkpoint control, and that its
function becomes particularly important in rapidly dividing
embryos or when embryos progress through critical, devel-
opmentally regulated cell-cycle transitions. ATM-depen-
dent signaling pathways may not be required for
development but are instead needed for efficient cancer
prevention and perhaps neuronal viability [13].
How does ATR prevent mitotic catastrophe? From work
on the yeast model system, Chk1 has long been
implicated as a downstream effector of ATR. Indirect
evidence that ATR regulates Chk1 in human cells has
been obtained by showing that overproduction of a
dominant-negative form of the ATR protein prevents
phosphorylation of Chk1 in response to UV treatment
[14]. Dunphy and colleagues [15] have recently shown
that ATR directly phosphorylates Chk1 at four distinct
SQ motifs — sites known to be preferred by ATM and
ATR — and obtained evidence that phosphorylation of
these residues is critical for Chk1 to prevent mitosis in
cycling Xenopus extracts after induction of the replication
checkpoint. Furthermore, the immunodepletion of ATR
from these extracts was found to cause premature entry
into mitosis, even when DNA replication was undis-
turbed, and this was associated with loss of Chk1 phos-
phorylation [15,16].
The fact that Chk1 is also essential for embryonic viability
in mice and Drosophila supports the view that ATR is
a direct regulator of Chk1. Elimination of either kinase,
Chk1 or ATR, results in mitotic catastrophe during
embryogenesis or loss of replication checkpoint control in
cycling Xenopus extracts [14,17–19]. A new concept is
emerging from these observations, which centers on the
idea that replication checkpoint signaling in higher
eukaryotes is constitutive, rather than induced: that is,
that the signals recognized by ATR are always present
when cells are undergoing DNA replication.
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Figure 1
A proposed model for the role of ATR and Chk1 in replication
checkpoint control. After the formation of preinitiation complexes —
represented by the binding of MCM, ORC and Cdc6 — and
subsequent loading of the initiation factors Cdc45, replication
factor A (RFA) and DNA polymerase α (Pol α/primase), ATR
becomes associated with chromatin. This association is dependent
on the ability of the primase component of DNA polymerase α to
synthesize RNA required to prime lagging-strand DNA synthesis.
Inhibition of DNA polymerase α by aphidicolin causes extensive
unwinding of DNA that in turn may promote increased association of
the replication initiation factors — Cdc45, RFA and DNA
polymerase α — with DNA. Aphidicolin treatment could also increase
the number of stalled replication forks and in this way increase ATR
association with chromatin. ATR then transduces the checkpoint
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What is the connection between ATR and DNA re-
plication? For over a decade, Xenopus egg extracts have
been used to study the entire process of DNA replication.
These extracts are capable of assembling added sperm
chromatin into nuclei, and support a complete round of
semi-conservative DNA replication that is dependent
upon the formation of pre-replication complexes — which
contain the ‘minichromosome maintenance’ (MCM) pro-
teins, the origin recognition complex (ORC) and Cdc6 —
and subsequent loading of factors critical for establishing
the initiation complex, such as Cdc45, replication factor A
and DNA polymerase α [20].
As recently published in Current Biology, Hekmat-Nejad
et al. [16] have found that Xenopus ATR associates with
sperm chromatin only during DNA replication, and that
binding is enhanced if the DNA replication checkpoint
is induced by treating the extracts with aphidicolin, an
inhibitor of DNA polymerase α [16]. Furthermore, inhibit-
ing the RNA-priming function of DNA polymerase α, nec-
essary for both DNA replication initiation and replication
checkpoint competence in Xenopus extracts, prevented
ATR from associating with sperm chromatin [16,21].
Together, these results suggest that ATR may recognize
primed DNA replication intermediates or associated pro-
teins that are increased in quantity, or altered in some way,
if the DNA synthesizing function of DNA polymerase α is
inhibited (Figure 1). This model is based on the observa-
tion that treatment of Xenopus extracts with aphidicolin
causes extensive DNA unwinding and increases the
loading of Cdc45, replication factor A and polymerase α
onto sperm chromatin or plasmid DNA [21,22]. On this
note, it is intriguing that ATR was found to colocalize with
sites of stalled replication forks after mammalian cells were
exposed to aphidicolin [9]. 
Does ATR function alone, or do other putative DNA-
interacting proteins participate in this pathway? In fission
yeast, genetic evidence pointed to a model in which the
other five checkpoint Rad proteins — Rad1, Rad9,
Rad17, Rad26 and Hus1 — sense alterations in DNA
structures and cooperate to send a signal through Rad3
[1]. This model has recently been challenged after the
demonstration that Rad3 checkpoint function can be
detected in the absence of several Rad genes, suggesting
that Rad3 may directly sense alterations in DNA struc-
ture [23]. Even so, these genes are still needed for Rad3
to convey its signal to Chk1 and this dependence may
also be true in mammalian systems. Disruption of Hus1
is embryonic lethal in mice and, similar to the situation
when ATR is deficient, Hus1–/– embryos and cells are
associated with extensive chromosomal aberrations and
display increased sensitivity to UV and hydroxyurea [24].
Hus1 may therefore be involved in the same pathway that
uses ATR and Chk1 to transduce checkpoint signals
(Figure 1).
In both fission yeast and mammals, Hus1 physically
interacts with Rad1 and Rad9, forming a complex that
is structurally related to the ‘proliferating cell nuclear
antigen’, PCNA [25–27]. PCNA clamps onto DNA as a
trimeric complex and act as a DNA polymerase accessory
factor [28]. Rad17 shows sequence similarity to compo-
nents of replication factor C (RFC), a complex of five pro-
teins required for loading of PCNA onto DNA at
primer–template junctions [28]. Whether Rad17 cooper-
ates with RFC proteins to load the Rad1–Rad9–Hus1
complex onto damaged or unreplicated DNA is not
known, though Rad17 has been shown to associate with
the Rad1–Rad9–Hus1 complex in vivo [29]. The similari-
ties in structure of Rad17 and the Rad1–Rad9–Hus1
complex to RFC proteins and PCNA, respectively, are
intriguing given the new observations of replication-
dependent association of ATR with chromatin in Xenopus
extracts and with stalled DNA replication forks in mam-
malian somatic cells. Whether these proteins interact with
ATR to carry out DNA replication and/or DNA damage
checkpoint functions will certainly be an area of active
research in the future.
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